You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Starbreeze Q3´24: PAYDAY 3 keeps improving but player activity remains muted
Following Starbreeze's Q3 report, we took the opportunity to interview the company's acting CEO and CFO, Mats Juhl, to gain deeper insights into the latest results. Mats shares his thoughts on the activity around PAYDAY 3, the upcoming Project Baxter, Roboquest, and key areas to watch in the coming quarters.
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
Titta på alla videor